04/21/2016 / By Claire Rankin
Research into the use of cannabis and cannbinoids has been studied to some extent, for conditions such as pain relief, nausea, vomiting, anxiety and so on. In fact, two cannabinoids (dronabinol and nabilone) are approved by the FDA for the treatment of chemotherapy related nausea and vomiting.
A lot of cannabis research cannot be undertaken at the moment, because marijuana is outlawed and branded as a dangerous drug with no medicinal value. However, scientists in other countries have studied the molecular activity of cannabinoids. For example, Spanish molecular biologist Christina Sanchez from the Compultense University in Madrid has been studying cannabinoids and has leaned that tetrahydrocannabinol (THC), the pshychoactive component of cannabis, causes tumor cells to die (apoptosis), while leaving healthy cells alone. These findings were published in a paper on the anti-cancer effects of THC in the European biochemistry journal FEBS Letters.
More studies highlighting the potential of cannabis for brain cancer
The human body is designed to utilize cannabis compounds, research from the 1980s shows. The body contains two targets for THC, the psychoactive compound of the marijuana plant, therefore the human body benefits from the cannabinoids found in cannabis. Research on animals has proven that cannabinoids help to inhibit tumor growth in three ways: by causing cell death, blocking cancer cell growth and preventing the development of blood vessels needed by tumors in order to grow.
Sources:
http://www.jneurosci.org/content/21/17/6475.abstract
http://jpet.aspetjournals.org/content/308/3/838.abstract
http://www.naturalnews.com/048913_cannabis_cancer_treatment_herbal_medicine.html
Tagged Under: cannabidiol, Cannabinoids, Cannabis research and brain cancer